Search Within

Molecular Imaging and Therapy Service

Formats
  1. Journal Article (1834)
  2. Meeting Abstract (941)
  3. Book Section (179)
  4. Review (161)
  5. Editorial (45)
  6. Conference Paper (40)
  7. Guidelines (32)
  8. Miscellaneous (19)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (7)
Groups
  1. Radiology, Department of (3103)
  2. GSK Faculty (1491)
  3. Sloan Kettering Institute Faculty (1250)
  4. Molecular Pharmacology and Chemistry Program Faculty (1235)
  5. Department of Medicine (1003)
  6. Sloan Kettering Institute Postdocs (885)

More Groups

People
  1. Steven Larson (962)
  2. Heiko Schoder (555)
  3. Neeta Pandit-Taskar (348)
  4. John Humm (284)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (211)

More People

Years
  1. 2025 (75)
  2. 2024 (134)
  3. 2023 (176)
  4. 2022 (176)
  5. 2021 (200)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (577)
  2. Journal of Clinical Oncology (251)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (102)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (577)
  2. Springer (434)
  3. Elsevier Inc. (286)
  4. American Society of Clinical Oncology (263)
  5. Lippincott Williams & Wilkins (155)
  6. American Association for Cancer Research (151)

More Publishers

Results (3281)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Iomab with adoptive cellular therapy (Iomab-ACT): A pilot study of 131-I apamistamab followed by CD19-targeted car T-cell therapy for patients with relapsed or refractory B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma
    Meeting Abstract

    Geyer, M. B.; Cadzin, B.; Halton, E.; Kane, P.; Senechal, B.; Geoghegan, E. M.; Reddy, V.; Berger, M. S.; Ludwig, D.; Pandit-Taskar, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Effect of brentuximab vedotin addition to chemotherapy and prognostic factors in patients with relapsed/refractory hodgkin lymphoma: A large multi-trial analysis based on individual patient data
    Meeting Abstract

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L. L.; LaCasce, A. S.; Moskowitz, C. H.; Garcia-Sanz, R.; Cole, P. D.; Fuchs, M.; Mueller, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Trial-in-progress: Randomized phase II trial in early relapsing or refractory follicular lymphoma (NCT# 03269669): SWOG S1608
    Meeting Abstract

    Barr, P. M.; Li, H.; Link, B. K.; Flowers, C. R.; Burack, R.; Schöder, H.; Leblanc, M. L.; Weigert, O.; Herrera, A. F.; Weinstock, D. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Quantifying intrathecal drug delivery utilizing programmable ventriculoperitoneal shunts
    Meeting Abstract

    McThenia, S.; Pandit-Taskar, N.; Grkovski, M.; Donzelli, M.; Diagana, S.; Greenfield, J.; Souweidane, M.; Kramer, K.
    Neuro-Oncology Advances (2021)

    Fulltext@MSK | Save
  • Clinical utility of (18)F-FDG PET/CT for staging and treatment planning in urachal adenocarcinoma
    Journal Article

    Das, J. P.; Vargas, H. A.; Ghafoor, S.; Goh, A. C.; Ulaner, G. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® Transgender Breast Cancer Screening
    Guidelines

    Brown, A.; Lourenco, A. P.; Niell, B. L.; Cronin, B.; Dibble, E. H.; DiNome, M. L.; Goel, M. S.; Hansen, J.; Heller, S. L.; Jochelson, M. S.; more...
    Journal of the American College of Radiology (2021)

    Fulltext@MSK | Save
  • Facile synthesis of near-infrared bodipy by donor engineering for in vivo tumor targeted dual-modal imaging
    Journal Article

    An, F.; Xin, J.; Deng, C.; Tan, X.; Aras, O.; Chen, N.; Zhang, X.; Ting, R.
    Journal of Materials Chemistry B (2021)

    Fulltext@MSK | Save